Vaccine News and Research

Latest Vaccine News and Research

UAB will collaborate with Altimmune to test a COVID-19 vaccine candidate

The University of Alabama at Birmingham is launching a collaboration with the biopharmaceutical company Altimmune, Inc. for preclinical testing of a potential vaccine to prevent COVID-19 disease.

30 Mar 2020

How long to a coronavirus vaccine?

The whole world is waiting for one. A vaccine is the only thing that could conceivably save the world from a horrifying cascade of deaths, other than a miracle, it seems.

29 Mar 2020

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

All over the world, except in China, the place where it all began, the COVID-19 pandemic is making its relentless way through the population. So far, it has caused nearly 34,000 deaths – and the situation in the US is still worsening with over 142,000 cases and 2,489 deaths. In Australia, the number of cases has climbed to 4,093, with 16 fatalities.

29 Mar 2020

New test uses saliva sample to provide immediate hepatitis B diagnosis

Viruses are sneaky beings. As the coronavirus pandemic is demonstrating, they cross borders quickly and can be highly contagious before symptoms of disease break out. In many cases of infection, a clear path of transmission cannot be determined.

27 Mar 2020

Research offers hope for increasing the robustness of vaccine response in older people

Research just published by the Linterman lab shows that the immune system of older mice can be given a helping hand by applying immunology expertise and some genital wart treatment (don't try this at home just yet)!

27 Mar 2020

Disasters have a major impact on cervical cancer screening for years

Cervical cancer screening rates in Japan were significantly affected in the years following the devastating Great East Japan Earthquake of 2011, Tohoku University scientists report in the journal PLOS ONE.

27 Mar 2020

Microbiome could help identify pre-cancer risk in women with HPV

A new study published in the open-access journal PLOS Pathogens in March 2020 reports the possible use of the bacteria Gardnerella found in the cervix and vagina of women with Human papillomavirus (HPV) infection, as a marker of precancerous change. The findings could help to find new methods of treatment that involve inducing changes in the microbiome to arrest the course of the disease.

26 Mar 2020

New research initiative to investigate multi-species response to novel coronavirus

Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).

26 Mar 2020

A quest to unlock the genetic code of SARS-CoV-2

How the novel coronavirus that causes COVID-19 made the leap from animals to humans is a puzzle that scientists are trying to solve as humanity comes to grip with the deadly pandemic sweeping the globe.

26 Mar 2020

Dutch citizens prepared to give EU a more central role in fighting epidemic

Dutch citizens are prepared to give the European Union a more central role when it comes to fighting an epidemic.

26 Mar 2020

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Today Berkeley Lights, Inc., announced the GEPAD with the aim to accelerate the discovery of neutralizing antibodies from patient blood samples.

From Bruker Cellular Analysis 26 Mar 2020

Murdoch Children's Research Institute to roll-out clinical trial of BCG vaccine against COVID-19

Professor Kathryn North AC, Director of the Murdoch Children's Research Institute in Melbourne, Australia, has announced its infectious disease researchers are preparing to roll-out a multi-center randomized controlled clinical trial of the BCG vaccine against COVID-19.

26 Mar 2020

Mologic and partners begin validation process for COVID-19 point-of-need diagnostic test

Mologic Ltd today announced that it has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School of Tropical Medicine.

26 Mar 2020

Coronavirus is not mutating rapidly, hope for vaccine development

Despite the coronavirus infection numbers skyrocketing, there is still good news. A team of scientists found that the novel coronavirus is not mutating significantly, suggesting any vaccine developed to fight SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) would remain effective in the long term.

25 Mar 2020

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.

25 Mar 2020

Academy calls on Australian Government to publish scientific evidence supporting COVID-19 decisions

The global COVID-19 pandemic affects all Australians and their loved ones at home and abroad. It is having a profound and enduring impact on our society, our resilience and our health.

25 Mar 2020

One in five childhood deaths in England and Wales still due to infection

A new study published in the journal Archives of Diseases of Childhood in March 2020 reveals that despite a drop to less than half, compared to 25 years ago, infection is still a cause of significant mortality among children. The most common cause of infection-related deaths in this age group are respiratory infections.

24 Mar 2020

German scientists test TB vaccine against coronavirus

The coronavirus disease (COVID-19) had taken a toll on the world, affecting 168 countries and more than 417,000 people. So far, more than 18,600 people have died due to complications of the disease. Scientists across the globe race to develop the first vaccine against the novel coronavirus.

24 Mar 2020

New Australian pilot program to monitor the effects of flu vaccines

A new Australian pilot program led by The University of Western Australia, in partnership with SmartVax, MedAdvisor and the Queensland University of Technology, will monitor the effects of flu vaccines administered by pharmacists this flu season.

24 Mar 2020

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

The U.K. government backs six projects aimed to fight the coronavirus outbreak, promising $23 million (£20 million) in funding. The projects, including two focused on vaccination trials, will help fast track the development of a vaccine to stop the spread of the coronavirus, leading to the death of more than 16,500 people across the globe.

24 Mar 2020